Biotech vs COVID-19: The Role of Emerging Tech in the Fight Against COVID-19 (Part 2)

Biotech vs COVID-19: The Role of Emerging Tech in the Fight Against COVID-19 (Part 2)

0 0 2 months ago
This is part 2 of our event with BioIDEA: Biotech vs COVID-19

BioIDEA and EVQLV hosted a panel discussion and Q&A on the role of emerging technologies in the fight against COVID-19.

Our panelists included Elena Diez Cecilia, Director of Business Development and R&D Strategy at A2A Pharmaceuticals, Ed Painter, Chairman and CIO of A2A Pharmaceuticals; Peter Leonardi, CEO and Founder of OmniCyte; and our very own Andrew Satz, CEO and Co-Founder of EVQLV.

More from BioIDEA: ... See More

Find us on Facebook

iAB member
Copyright 2020 - Spreaker Inc. a Voxnest Company - Create a podcast - New York, NY
Help